Skip to main content

Deferoxamine Pregnancy and Breastfeeding Warnings

Brand names: Desferal

Medically reviewed by Drugs.com. Last updated on Dec 2, 2024.

Deferoxamine Pregnancy Warnings

This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.

AU TGA pregnancy category: B3
US FDA pregnancy category: Not assigned.

Risk summary: No data are available on the use of this drug in pregnant patients to inform a drug-related risk.

Comments:
-This drug can harm a developing fetus.
-Effective contraception in females of reproductive potential and male patients with female partners of reproductive potential should be used during therapy and for 1 month after the last dose; local protocol should be consulted regarding contraception timing.

Animal studies showed delayed ossification and skeletal anomalies. There are no controlled data in human pregnancy.

AU TGA pregnancy category B3: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Deferoxamine Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

See references

Does Deferoxamine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. (2001) "Product Information. Desferal (deferoxamine)." Novartis Pharmaceuticals
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  3. Cerner Multum, Inc. "Australian Product Information."
  4. (2015) "Product Information. Deferoxamine Mesylate (deferoxamine)." Hospira Inc
  5. (2022) "Product Information. Desferal (deferoxamine)." Novartis Pharmaceuticals

References for breastfeeding information

  1. (2001) "Product Information. Desferal (deferoxamine)." Novartis Pharmaceuticals
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  3. (2015) "Product Information. Deferoxamine Mesylate (deferoxamine)." Hospira Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer